The Tryptophan Metabolic Pathway of the Microbiome and Host Cells in Health and Disease

Overview

Journal Int Immunol

Specialty Allergy & Immunology

Date 2024 Jun 13

PMID 38869080

Authors

Kentaro Miyamoto

Tomohisa Sujino

Takanori Kanai

Affiliations

Soon will be listed here.

Abstract

The intricate and dynamic tryptophan (Trp) metabolic pathway in both the microbiome and host cells highlights its profound implications for health and disease. This pathway involves complex interactions between host cellular and bacteria processes, producing bioactive compounds such as 5-hydroxytryptamine (5-HT) and kynurenine derivatives. Immune responses to Trp metabolites through specific receptors have been explored, highlighting the role of the aryl hydrocarbon receptor in inflammation modulation. Dysregulation of this pathway is implicated in various diseases, such as Alzheimer's and Parkinson's diseases, mood disorders, neuronal diseases, autoimmune diseases such as multiple sclerosis (MS), and cancer. In this article, we describe the impact of the 5-HT, Trp, indole, and Trp metabolites on health and disease. Furthermore, we review the impact of microbiome-derived Trp metabolites that affect immune responses and contribute to maintaining homeostasis, especially in an experimental autoimmune encephalitis model of MS.

Citing Articles

Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn's disease.

Sigall Boneh R, van der Kruk N, Wine E, Verburgt C, de Meij T, Lowenberg M Therap Adv Gastroenterol. 2025; 18:17562848251323004.

PMID: 40012837 PMC: 11863242. DOI: 10.1177/17562848251323004.

Non-targeted metabolomic profile of Leuconostoc mesenteroides-fermented milk reveals differentially expressed metabolites associated with electro-fermentation.

Huang T, Yang J Microb Cell Fact. 2025; 24(1):46.

PMID: 39987182 PMC: 11847352. DOI: 10.1186/s12934-025-02673-5.

Tryptophan metabolism-related gene CYP1B1 serves as a shared biomarker for both Parkinson's disease and insomnia.

Li X, Yu W, Wu J, He W, Cheng Y, Gao K Sci Rep. 2025; 15(1):1362.

PMID: 39779759 PMC: 11711247. DOI: 10.1038/s41598-024-84362-8.

Caveolae with serotonin and NMDA receptors as promising targets for the treatment of Alzheimer's disease.

Nakashima M, Suga N, Fukumoto A, Yoshikawa S, Matsuda S Int J Physiol Pathophysiol Pharmacol. 2024; 16(5):96-110.

PMID: 39583750 PMC: 11579522. DOI: 10.62347/MTWV3745.

Indole-3-Carboxaldehyde Alleviates LPS-Induced Intestinal Inflammation by Inhibiting ROS Production and NLRP3 Inflammasome Activation.

Cao J, Bao Q, Hao H Antioxidants (Basel). 2024; 13(9).

PMID: 39334766 PMC: 11429283. DOI: 10.3390/antiox13091107.

References

Sun T, Xie R, He H, Xie Q, Zhao X, Kang G . Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization GPR35. Front Immunol. 2022; 13:1019365. PMC: 9606686. DOI: 10.3389/fimmu.2022.1019365. View

Zadori D, Veres G, Szalardy L, Klivenyi P, Vecsei L . Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines. J Alzheimers Dis. 2018; 62(2):523-547. DOI: 10.3233/JAD-170929. View

Gargaro M, Scalisi G, Manni G, Briseno C, Bagadia P, Durai V . Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication. Immunity. 2022; 55(6):1032-1050.e14. PMC: 9220322. DOI: 10.1016/j.immuni.2022.05.013. View

Shimada Y, Kinoshita M, Harada K, Mizutani M, Masahata K, Kayama H . Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon. PLoS One. 2013; 8(11):e80604. PMC: 3835565. DOI: 10.1371/journal.pone.0080604. View

Pukoli D, Polyak H, Rajda C, Vecsei L . Kynurenines and Neurofilament Light Chain in Multiple Sclerosis. Front Neurosci. 2021; 15:658202. PMC: 8185147. DOI: 10.3389/fnins.2021.658202. View

Xu L, Ling J, Su C, Su Y, Xu Y, Jiang Z . Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries. Front Med (Lausanne). 2021; 8:756435. PMC: 8636938. DOI: 10.3389/fmed.2021.756435. View

Kaya B, Melhem H, Hendrik Niess J . GPR35 in Intestinal Diseases: From Risk Gene to Function. Front Immunol. 2021; 12:717392. PMC: 8591220. DOI: 10.3389/fimmu.2021.717392. View

Agus A, Planchais J, Sokol H . Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018; 23(6):716-724. DOI: 10.1016/j.chom.2018.05.003. View

Wang X, Hawkins B, Miller D . Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS. J Cereb Blood Flow Metab. 2011; 31(6):1371-5. PMC: 3130326. DOI: 10.1038/jcbfm.2011.44. View

10.

Szalardy L, Zadori D, Toldi J, Fulop F, Klivenyi P, Vecsei L . Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction. Curr Top Med Chem. 2012; 12(16):1797-806. View

11.

Roager H, Licht T . Microbial tryptophan catabolites in health and disease. Nat Commun. 2018; 9(1):3294. PMC: 6098093. DOI: 10.1038/s41467-018-05470-4. View

12.

Fila M, Chojnacki J, Pawlowska E, Szczepanska J, Chojnacki C, Blasiak J . Kynurenine Pathway of Tryptophan Metabolism in Migraine and Functional Gastrointestinal Disorders. Int J Mol Sci. 2021; 22(18). PMC: 8469852. DOI: 10.3390/ijms221810134. View

13.

Tufvesson-Alm M, Schwieler L, Schwarcz R, Goiny M, Erhardt S, Engberg G . Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia. Neuropharmacology. 2018; 138:130-139. PMC: 6794148. DOI: 10.1016/j.neuropharm.2018.06.003. View

14.

Esser C, Rannug A, Stockinger B . The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009; 30(9):447-54. DOI: 10.1016/j.it.2009.06.005. View

15.

Guo S, Vecsei L, Ashina M . The L-kynurenine signalling pathway in trigeminal pain processing: a potential therapeutic target in migraine?. Cephalalgia. 2011; 31(9):1029-38. DOI: 10.1177/0333102411404717. View

16.

Arifuzzaman M, Collins N, Guo C, Artis D . Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation. Immunity. 2024; 57(1):14-27. PMC: 10795735. DOI: 10.1016/j.immuni.2023.12.009. View

17.

Kaya B, Donas C, Wuggenig P, Diaz O, Morales R, Melhem H . Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1 Macrophages Regulates Intestinal Homeostasis. Cell Rep. 2020; 32(5):107979. DOI: 10.1016/j.celrep.2020.107979. View

18.

Li S, Bostick J, Zhou L . Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor. Front Immunol. 2018; 8:1909. PMC: 5760495. DOI: 10.3389/fimmu.2017.01909. View

19.

Pierozan P, Pessoa-Pureur R . Cytoskeleton as a Target of Quinolinic Acid Neurotoxicity: Insight from Animal Models. Mol Neurobiol. 2017; 55(5):4362-4372. DOI: 10.1007/s12035-017-0654-8. View

20.

Iacone R, Scanzano C, Santarpia L, Cioffi I, Contaldo F, Pasanisi F . Macronutrients in Parenteral Nutrition: Amino Acids. Nutrients. 2020; 12(3). PMC: 7146427. DOI: 10.3390/nu12030772. View